Foundation Medicine to provide Celgene with cancer genomics tests

05/19/2011 | Mass High Tech (Boston)

Foundation Medicine has partnered with Celgene to supply the company with its genetic tests for cancer. Under the deal, Celgene will use the tests to look at the genetic traits of patients enrolled in clinical trials of drugs for various diseases, such as multiple myeloma and prostate cancer.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN